Search Site

Trends banner

Luberef net profit falls 7% in Q1

A fall in by-products sales leads to profit dip.

SABIC net loss $322 million

The company's net profit was $66m in Q1 2024

PureHealth posts $137m Q1 net profit

The Group's revenue increased 8 percent YoY.

Borouge Q1 net profit $281 million

The total dividend paid to shareholders in 2024 $1.3bn.

Emirates expects first 777X delivery in H2 2026

Boeing had pushed back the first delivery to 2026 from 2025.

Global vaccine program COVAX seeks $5.2b in funding

COVAX's initial goal was to deliver 2 billion doses by the end of 2021. AFP
  • COVAX's initial goal was to deliver 2 billion doses by the end of 2021, but its lack of cash when vaccine deals were made delayed its delivery
  • Nearly 1 billion doses of the United Nations-backed COVAX program have been delivered since the shipments began nearly a year ago

The global initiative to share Coronavirus vaccines equally between rich and poor countries is seeking $5.2 billion in funding in order to be able to continue to purchase vaccines in the coming months.

Approximately 1 billion doses of the United Nations-backed COVAX program have been delivered since the shipments began nearly a year ago, according to an Associated Press report.

COVAX’s initial goal was to deliver 2 billion doses by the end of 2021, but its lack of cash when vaccine deals were made delayed its delivery, and the majority of vaccine doses have gone to wealthy nations that are locked into contracts.

At present, less than 10% of people in low-income countries have received at least one dose, while more than 60% of the world’s total population has been immunized, some with three or four doses.